Artwork
iconShare
 
Manage episode 514724037 series 3646445
Content provided by Brad Hightower. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brad Hightower or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode, we dive deep into the growing influence of private equity on Institutional Review Boards (IRBs), the challenges of maintaining transparency and avoiding conflicts of interest, and the explosion of data collection in modern clinical trials. We also discuss the promises and pitfalls of AI in research, share personal stories from the field, and reflect on the latest industry news and conferences.

  continue reading

100 episodes